Join California Life Sciences at BIO International Convention, June 3-6 in San Diego, where you’ll experience more than 100 sessions, an exhibition hall with 900+ booths and international pavilions, and exciting keynotes. Sign up for a Premier Access pass—the all-inclusive way to experience BIO 2024—and gain access to the BIO One-on-One Partnering™ system, where you can request and accept meetings from potential partners.
Visit CLS at Booth #2625, directly across from the BIO Pavilion and Business Forum, to learn more about California Life Sciences and how we support the life sciences sector. Other partners represented in the California Pavilion include: Ardena, Azzur Group, ChemDiv, Marcum, SDSU, SmartLabs, Ritchr Financial Studio among others. Become a a part of the California Pavillion by contacting Emily Morgan, Senior Director, Marketing & Programs, to learn more.
Make sure to visit us Monday afternoon for our Welcome to San Diego Reception and again Tuesday afternoon for our Exhibitor Hospitality Reception where you can meet with the various sponsors and partners of the California Pavilion!
After a day full of BD meetings and relationship building on the show floor, drop by the CLS reception to mingle with more than 300 of your closest industry friends. This event is by invitation-only and is first come, first serve to handle venue capacity.
Please contact [email protected] to learn more.
Please contact Emily Morgan, [email protected] to learn more about sponsorship opportunities.
California Life Sciences is proud to present former FAST alumni and other women-led startup companies in this year’s BIO Start-Up Stadium. Start-Up Stadium is designed to provide start-up companies with the opportunity to engage key members of the investment community, venture philanthropy groups, strategic partners, and non-dilutive capital at the world’s largest biotechnology partnering event. During the 2024 BIO International Convention, select finalists from around the world will share a quick pitch showcasing new technologies and therapeutic solutions to a panel of investor judges, followed by live feedback.
